Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 10 Jun 2013

Vignot Stéphane, Frampton Garrett M, Soria Jean-Charles, Yelensky Roman, Commo Frédéric, Brambilla Christian, Palmer Gary, Moro-Sibilot Denis, Ross Jeffrey S, Cronin Maureen T, André Fabrice, Stephens Philip J, Lazar Vladimir, Miller Vincent A, Brambilla Elisabeth

Abstract excerpt

PURPOSE: Characterization of the genomic changes that drive an individual patient's disease is critical in management of many cancers. In patients with non-small-cell lung cancer (NSCLC), obtaining tumor samples of sufficient size for genomic profiling on recurrence is often challenging. We under...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Base Sequence

Share to Carcinoma, Non-Small-Cell Lung

Share to DNA Copy Number Variations

Share to DNA, Neoplasm

Share to Lung Neoplasms

Share to Neoplasm Metastasis

Source

Identifiers

PMID: 23630207
DOI: 10.1200/JCO.2012.47.7737

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23630207-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancer.PMID 23630207Read ↗

Genomic profiling implicates candidate genes and mutagenic pathways driving lung cancer recurrenceSemantic proximity Read ↗

Targeted next-generation sequencing assays using triplet samples of normal breast tissue, primary breast cancer, and recurrent/metastatic lesionsSemantic proximity Read ↗

Targeted next-generation sequencing assays using triplet samples of normal breast tissue, primary breast cancer, and recurrent/metastatic lesions.Semantic proximity Read ↗

Next-generation sequencing reveals remarkable genetic stability in primary and corresponding recurrent intestinal-type sinonasal adenocarcinoma.Semantic proximity Read ↗

Whole-Exome Sequencing Reveals High Mutational Concordance between Primary and Matched Recurrent Triple-Negative Breast Cancers.Semantic proximity Read ↗

Temporal genomic heterogeneity guiding individualized therapy in recurrent non-small cell lung cancerSemantic proximity Read ↗

Targeted Next-Generation Sequencing Analysis for Recurrence in Early-Stage Lung Adenocarcinoma.Semantic proximity Read ↗

Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma.Semantic proximity Read ↗

Spatiotemporal genomic analysis reveals distinct molecular features in recurrent stage I non-small cell lung cancers.Semantic proximity Read ↗

Concordance of genomic alterations between primary and recurrent breast cancer.Semantic proximity Read ↗

Actionable Gene Alterations in Resected Non-Small Cell Lung Cancer: Primary Results From the AGA-R Study.Semantic proximity Read ↗

Conserved recurrent gene mutations correlate with pathway deregulation and clinical outcomes of lung adenocarcinoma in never-smokers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.